Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
5.14
-0.02 (-0.39%)
At close: Mar 10, 2026, 4:00 PM EDT
5.33
+0.19 (3.70%)
After-hours: Mar 10, 2026, 7:24 PM EDT
Abeona Therapeutics Employees
Abeona Therapeutics had 136 employees as of December 31, 2024. The number of employees increased by 52 or 61.90% compared to the previous year.
Employees
136
Change (1Y)
52
Growth (1Y)
61.90%
Revenue / Employee
$2,941
Profits / Employee
$605,515
Market Cap
278.54M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 136 | 52 | 61.90% |
| Dec 31, 2023 | 84 | 27 | 47.37% |
| Dec 31, 2022 | 57 | -33 | -36.67% |
| Dec 31, 2021 | 90 | 14 | 18.42% |
| Dec 31, 2020 | 76 | -12 | -13.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 222 |
| AC Immune | 172 |
| Coherus Oncology | 158 |
| Silence Therapeutics | 116 |
| OmniAb | 114 |
| Enlivex | 71 |
| Orchestra BioMed Holdings | 70 |
| Cybin | 50 |
ABEO News
- 1 day ago - Abeona Therapeutics® Provides Business Update Highlighting Building Momentum in ZEVASKYN® Commercial Launch - GlobeNewsWire
- 7 days ago - Abeona Therapeutics® Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer - GlobeNewsWire
- 3 months ago - Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas - GlobeNewsWire
- 3 months ago - Abeona Therapeutics® Announces First Patient Treatment with ZEVASKYN® Gene Therapy - GlobeNewsWire
- 4 months ago - Abeona Therapeutics Q3 2025: Strong Financials And Zevaskyn Launch Ahead - Seeking Alpha
- 4 months ago - Abeona Therapeutics Inc. (ABEO) Q3 2025 Earnings Call Transcript - Seeking Alpha